Fulton Breakefield Broenniman’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-32,748
| Closed | -$4.01M | – | 118 |
|
|
2016
Q3 | $4.01M | Sell |
32,748
-1,752
| -5% | -$215K | 0.81% | 55 |
|
|
2016
Q2 | $4.03M | Buy |
34,500
+484
| +1% | +$56.5K | 0.82% | 53 |
|
|
2016
Q1 | $4.74M | Sell |
34,016
-1,279
| -4% | -$178K | 1.04% | 43 |
|
|
2015
Q4 | $6.73M | Buy |
35,295
+1,005
| +3% | +$192K | 1.49% | 24 |
|
|
2015
Q3 | $5.36M | Buy |
34,290
+8,783
| +34% | +$1.37M | 1.26% | 33 |
|
|
2015
Q2 | $4.61M | Buy |
+25,507
| New | +$4.61M | 1.01% | 46 |
|